ShareValue scores for INCR.TA: Valuation 57, Quality 38, Growth 49, Health 40.
INCR.TATASE
Intercure
₪2.85
(-1.32%)
INCR.TATASE
Intercure
₪2.85(-1.32%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Weak
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
6% to 17%
Rating
Trap Risk
Return
6% to 17%
Valuation
57
Fair Value
Price vs Value
Quality
38
Weak
Business Strength
Growth
49
Moderate
Revenue & Earnings
Health
40
Moderate
Financial Stability
Momentum
43
Neutral
Price Trend
Company Details
About
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
Market Cap$169M
P/E RatioN/A
Dividend YieldNone
Sector Rank#1893
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026